The sixth annual World Cancer Series: Europe, this November 9-13, will feature a special session on Access to Clinical trials, with Teodora Kolarova, INCA Executive Director, as a panelist. By demonstrating what works and what doesn’t, clinical trials are crucial to improving cancer control. Cancer patients who have enrolled in clinical trials have better outcomes than those who have not. Yet while most patients are willing to participate in trials, only a minority do. The discussion will explore the reasons patients don’t have access to clinical trials, why these inequalities exist, and how this situation can be improved.
The World Cancer Series: Europe is an annual event of The Economist that gathers senior policy-makers, clinicians, industry leaders, academics and patient advocates to drive forward the conversation on improving the provision of cancer care in Europe.